Mark S Cohen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Metastatic Colorectal Cancer

Structure Activity Relationship

Top Venues

RSC medicinal chemistry

Expert opinion on drug discovery

University of Michigan

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Michigan

United States

Associate Chair In Innovation and Entrepreneurship/Associate Professor of Surgery and Pharmacology :: Surgery

Publications

Eva Amatya, Chitra Subramanian, Mark S Cohen, Brian S J Blagg
Development of Hsp90 C-terminal inhibitors with noviomimetics that manifest anti-proliferative activities. RSC medicinal chemistry 15 (3) (2024)
Eva Amatya, Chitra Subramanian, Mark S Cohen, Brian S J Blagg
Development of Hsp90 C-terminal inhibitors with noviomimetics that manifest anti-proliferative activities. RSC medicinal chemistry 15 (3) (2024)
Monica K Chanda, Mark S Cohen
Advances in the discovery and development of melanoma drug therapies. Expert opinion on drug discovery 16 (11) (2021)
Jaquelyn N Sanchez, Ton Wang, Mark S Cohen
BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers. Drugs 78 (5) (2019)